Dr Reddy's Laboratories said it has successfully completed the full set of clinical studies of its proposed rituximab biosimilar candidate, 'DRL_RI' for filing in highly regulated markets such as the US, Europe and other regions...
Sun Pharmaceutical Industries Limited, India's largest drugmaker, said it will acquire U.S.-based Concert Pharmaceuticals for $576 million in cash to gain access to its experimental drug for treating patchy baldness...
Alembic Pharmaceuticals Limited, an R&D pharmaceutical firm, announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Acalabrutinib Capsules, 100 mg, used for...
Calibre Scientific, a global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities, has announced the acquisition of Glass Chemicals, a Spanish...
Cipla, a pharmaceutical company, announced the launch of a diagnostic device for a variety of conditions such as diabetes, infectious diseases, and thyroid function. Cippoint, a point-of-care testing device, offers a wide range of testing...
Sebi has approved pharmaceutical companies Innova Captab Ltd and Blue Jet Healthcare to raise funds through an initial public offering (IPO). According to an update with Sebi, the two firms that filed their preliminary papers with Sebi between...
Glenmark Pharmaceuticals Ltd. has introduced'sacubitril + valsartan' tablets in India, which are indicated for patients with chronic heart failure (NYHA class II-IV) and a low ejection fraction (HFrEF). It is marketed as 'Sacu VTM' and must be...
The Drug Controller General of India (DCGI) has approved the COVID-19 vaccine Covovax for marketing as a heterologous booster dose for adults who have received two doses of Covishield or Covaxin, according to official sources...
The first Health Working Group (HWG) meeting under G20 India Presidency will be held between January 18-20, in Kerala's Thiruvananthapuram. As chair of the G20 Presidency, India aims to continue and consolidate health priorities and key takeaways ...
Zydus Lifesciences has said it has received final approval from the US Food and Drug Administration (US FDA) to market Febuxostat tablets for 40 mg and 80 mg...
, CDSCO.jpg)
